Trial Profile
A Multicenter, Phase II Study Of Oxaliplatin Single Agent As Third-Line Treatment Of Metastatic Colorectal Carcinoma
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Oxaliplatin (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- 10 Sep 2005 New trial record.